Chinese Acute Ischemic Stroke Treatment Outcome Registry

Conditions

Ischemic Stroke

Brief summary

This is a multi-center registry study. The investigators will include 10,000 patients with confirmed acute ischemic stroke in China. The aim of the study is to survey current treatment situation in China and compare the effectiveness and safety between different intervention regimens.

Detailed description

Stroke is a common disease in China. Compared to western countries, there are many treatment regimens used in clinical practice in China. But their treatment effects are not well validated. The aim of the study is to survey current treatment situation in China and compare the effectiveness and safety between different intervention regimens.

Pingping Li, Min Zhao, Yining Huang, Weiping Sun, Luying Wang et al. (8 authors)

Health and Quality of Life Outcomes2026-03-21

10.1186/s12955-026-02524-w

Functional Outcomes of Human Urinary Kallindinogenases in Treatment of Acute Ischemic Stroke

Diandian Huang, Yuxuan Lu, Weiping Sun, Wei Sun, Yongan Sun et al. (16 authors)

Stroke2025-09-29

10.1161/strokeaha.124.050188

Comparison of Factors Affecting Quality of Life in Patients with Acute Ischemic Stroke Across Different Stroke Severities

Yuxuan Lu, Weiping Sun, Yining Huang, Li Cao, Zhiyuan Shen et al. (83 authors)

Neurology and Therapy2025-04-29

10.1007/s40120-025-00743-9

Measuring the health outcomes of Chinese ischemic stroke patients based on the data from a longitudinal multi-center study

Luying Wang, Xin‐Yuan Guan, Jiting Zhou, Hongfei Hu, Wei Liu et al. (10 authors)

Quality of Life Research2025-03-273 citations

10.1007/s11136-025-03957-4

Prolonged Hospital Length of Stay Does Not Improve Functional Outcome in Acute Ischemic Stroke.

Lu Y, Sun P, Jin H, Wang Z, Shen Z, Sun W, Sun Y, Liu R, Li F, Shu J, Qiu Z, Lu Z, Sun W, Zhu S, Huang Y, CASTOR Investigators.

2025-02-18

10.1007/s40120-025-00712-2

Geographic differences in pharmacotherapy patterns and outcomes of acute ischemic stroke in China.

Li Y, Ou Q, Lu Y, Shen Z, Li J, Zhang Z, Tai L, Li G, Chen H, Zhang G, Zhang L, Sun X, Qiu J, Wei Y, Zhu S, Wang Z, Sun W, Huang Y.

2024-02-151 citations

10.1186/s12883-024-03564-9

Chinese acute ischemic stroke treatment outcome registry (CASTOR): protocol for a prospective registry study on patterns of real-world treatment of acute ischemic stroke in China.

Sun W, Ou Q, Zhang Z, Qu J, Huang Y.

2017-07-0615 citations

10.1186/s12906-017-1863-4

Interventions

OTHERtreatment following current guideline

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

No

Inclusion criteria

1. age ≥18 yesrs 2. confirmed diagnosis of an ischemic stroke 3. admission within 1 week after onset of stroke or within treatment time window for patients of thrombolysis treatment 4. signed informed consent

Exclusion criteria

1. with intracerebral hemorrhage 2. with severe morbid (estimated survival duration less than 3 months) 3. could not provide follow-up information

Design outcomes

Primary

Measure	Time frame
death or severe disability	90 days

Countries

China

Contacts

Primary ContactYining Huang, MD

ynhuang@sina.com+86(10)83572857

Outcome results

None listed